BioSpace News Archive

AR in healthcare Market: Increase in incidence of diagnostic imaging to drive the market

Rise in use of augmented reality in the healthcare sector for various activities such as surgical simulation, diagnostic imaging, patient care management, and rehabilitation is boosting the sales opportunities in the global AR in healthcare market.

April 27, 2022
·
5 min read
Healthcare BPO Market: Growing prevalence of AI in disease diagnosis to drive the market

Healthcare services have been constantly evolving to balance the multiple aspects of managing operational costs, bottom-line of companies, and regulations all toward improving patient outcomes.

April 27, 2022
·
6 min read
Global Intraoperative Neuromonitoring (IONM) Market is Expected to Expand at a CAGR of 7.0% [Forecast 2022-2030]

The global intraoperative neuromonitoring market is expected to expand at a CAGR of 7.0% during the forecast period of 2014 to 2022 and gain a valuation of US$ 4,900 Mn by 2022.

April 27, 2022
·
9 min read
OKYO Pharma (“OKYO” or the “Company”) - Announces Two Presentations at the 2022 Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting

OKYO Pharma Limited announced that two presentations will be given on OKYO drug candidates OK-101 and OK-201 at the Association for Research and Vision in Ophthalmology Annual Meeting, to be held on May 1-4, 2022 in Denver, CO and virtually on May 11-12, 2022.

April 27, 2022
·
4 min read
Policy

Orexo’s partner Gesynta Pharma granted Orphan Drug Designation by the FDA for OX-MPI (GS-248) for the treatment of systemic sclerosis

Orexo AB, announces that the company´s partner Gesynta Pharma AB which owns all the rights to OX-MPI, a drug candidate for the treatment of systemic sclerosis, has been granted Orphan Drug Designation in the US by the Food and Drug Administration.

April 27, 2022
·
4 min read
Business

Samsung Biologics Reports First Quarter 2022 Financial Results

Samsung Biologics, the world’s leading contract development and manufacturing organization, announced strong financial results for the first quarter of fiscal year 2022.

April 27, 2022
·
3 min read
Business

RadNet, Inc. Announces the Date of its First Quarter 2022 Financial Results Conference Call

RadNet, Inc. announced that it will host a conference call to discuss its first quarter 2022 financial results on Monday, May 9th, 2022 at 7:30 a.m. Pacific Time.

April 27, 2022
·
1 min read
Business

Invitation to presentation of Q1 2022 report

Oncopeptides AB announces that it will present the interim report for the first quarter 2022 on May 4, at 11:00, and that the Annual General Meeting in Oncopeptides AB will be held on Tuesday June 28, 2022,.

April 27, 2022
·
2 min read
Genetown

Pressure BioSciences Announces Early Access Program for UST Nanoemulsion Processing

Pressure BioSciences, Inc. announced the initiation of an Early Access Program for the use of its revolutionary Ultra Shear Technology™ platform for the processing of oil-based active ingredients into highly stable, water soluble, long-term stable nanoemulsions.

April 27, 2022
·
8 min read
Pharm Country

Galera to Present at 2022 American Society of Clinical Oncology (ASCO) Annual Meeting

Galera Therapeutics, Inc. announced that clinical data from its Phase 3 ROMAN trial of avasopasem for severe oral mucositis will be presented in an oral presentation at the upcoming 2022 American Society of Clinical Oncology Annual Meeting, taking place June 3-7, 2022 in Chicago, Illinois.

April 27, 2022
·
2 min read